Video

New Onset Epilepsy & Chronological Age

Author(s):

Helen Scharfman, PhD, discusses the next steps of her research study at the American Epilepsy Society 2014 Annual Meeting.

Helen Scharfman, PhD, discusses the next steps of her research study at the American Epilepsy Society 2014 Annual Meeting.

"The idea here is an anti-epileptigenesis strategy. In aging it's really difficult, but I think it's really important, because it's a prevalent population," said Scharfman.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.